Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis.

Sloan RD, Kuhl BD, Mesplède T, Münch J, Donahue DA, Wainberg MA.

J Virol. 2013 Jul;87(14):8110-23. doi: 10.1128/JVI.00815-13. Epub 2013 May 15.

2.

Expansion of HIV-specific T follicular helper cells in chronic HIV infection.

Lindqvist M, van Lunzen J, Soghoian DZ, Kuhl BD, Ranasinghe S, Kranias G, Flanders MD, Cutler S, Yudanin N, Muller MI, Davis I, Farber D, Hartjen P, Haag F, Alter G, Schulze zur Wiesch J, Streeck H.

J Clin Invest. 2012 Sep;122(9):3271-80. doi: 10.1172/JCI64314. Epub 2012 Aug 27.

3.

The viral protein Tat can inhibit the establishment of HIV-1 latency.

Donahue DA, Kuhl BD, Sloan RD, Wainberg MA.

J Virol. 2012 Mar;86(6):3253-63. doi: 10.1128/JVI.06648-11. Epub 2012 Jan 11.

4.

The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism.

Kuhl BD, Cheng V, Donahue DA, Sloan RD, Liang C, Wilkinson J, Wainberg MA.

PLoS One. 2011;6(11):e27660. doi: 10.1371/journal.pone.0027660. Epub 2011 Nov 14.

5.

Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.

Kuhl BD, Sloan RD, Donahue DA, Liang C, Wainberg MA.

Virology. 2011 Sep 1;417(2):353-61. doi: 10.1016/j.virol.2011.06.012. Epub 2011 Jul 14.

6.

Tetherin and its viral antagonists.

Kuhl BD, Cheng V, Wainberg MA, Liang C.

J Neuroimmune Pharmacol. 2011 Jun;6(2):188-201. doi: 10.1007/s11481-010-9256-1. Epub 2011 Jan 11. Review.

7.

Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.

Sloan RD, Kuhl BD, Donahue DA, Roland A, Bar-Magen T, Wainberg MA.

J Virol. 2011 Mar;85(6):2828-36. doi: 10.1128/JVI.01854-10. Epub 2011 Jan 5.

8.

Tetherin restricts direct cell-to-cell infection of HIV-1.

Kuhl BD, Sloan RD, Donahue DA, Bar-Magen T, Liang C, Wainberg MA.

Retrovirology. 2010 Dec 24;7:115. doi: 10.1186/1742-4690-7-115.

9.

HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays.

Bar-Magen T, Donahue DA, McDonough EI, Kuhl BD, Faltenbacher VH, Xu H, Michaud V, Sloan RD, Wainberg MA.

AIDS. 2010 Sep 10;24(14):2171-9. doi: 10.1097/QAD.0b013e32833cf265.

PMID:
20647908
10.

Neither ritonavir nor darunavir affect cell surface expression of tetherin or Vpu-mediated tetherin down-modulation.

Kuhl BD, Sloan RD, Donahue DA, Bar-Magen T, Liang C, Wainberg MA.

AIDS. 2010 Jul 31;24(12):1970-2. doi: 10.1097/QAD.0b013e32833bfe3d. No abstract available.

PMID:
20622532
11.

Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor.

Bar-Magen T, Sloan RD, Donahue DA, Kuhl BD, Zabeida A, Xu H, Oliveira M, Hazuda DJ, Wainberg MA.

J Virol. 2010 Sep;84(18):9210-6. doi: 10.1128/JVI.01164-10. Epub 2010 Jul 7.

12.

Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes.

Sloan RD, Donahue DA, Kuhl BD, Bar-Magen T, Wainberg MA.

Retrovirology. 2010 May 13;7:44. doi: 10.1186/1742-4690-7-44.

13.

Stage-dependent inhibition of HIV-1 replication by antiretroviral drugs in cell culture.

Donahue DA, Sloan RD, Kuhl BD, Bar-Magen T, Schader SM, Wainberg MA.

Antimicrob Agents Chemother. 2010 Mar;54(3):1047-54. doi: 10.1128/AAC.01537-09. Epub 2009 Dec 28.

14.

Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes.

Bar-Magen T, Sloan RD, Faltenbacher VH, Donahue DA, Kuhl BD, Oliveira M, Xu H, Wainberg MA.

Retrovirology. 2009 Nov 11;6:103. doi: 10.1186/1742-4690-6-103.

Supplemental Content

Support Center